• Contact us
  • E-Submission
ABOUT
BROWSE ARTICLES
JOURNAL POLICIES
FOR CONTRIBUTORS

Page Path

  • HOME
  • Browse articles
  • Previous issues
5
results for

Previous issues

Filter

Article category

Keywords

Authors

Previous issues

Prev issue Next issue

Volume 44(2); April 2021

Editorial

[Korean]
Publication Ethics Part 1: Authorship
Ewha Med J 2021;44(2):31-33.   Published online April 30, 2021
DOI: https://doi.org/10.12771/emj.2021.44.2.31
  • 29 View
  • 1 Download

Letter to the Editor

[English]
Vision of Ewha in the COVID-19 Pandemic Era: A Note from the President
Eun Mee Kim
Ewha Med J 2021;44(2):34-36.   Published online April 30, 2021
DOI: https://doi.org/10.12771/emj.2021.44.2.34

Citations

Citations to this article as recorded by  
  • A creative and innovative platform leading a sustainable society by the 150th anniversary of Ewha Womans University: a presidential farewell address
    Eun Mee Kim
    The Ewha Medical Journal.2025;[Epub]     CrossRef
  • 46 View
  • 0 Download
  • 1 Web of Science
  • 1 Crossref

Review Article

[English]
Active Surveillance of Papillary Thyroid Cancer: Past, Present, and Future
Jong-Kyu Kim, Hyungju Kwon, Woosung Lim, Byung-In Moon, Nam Sun Paik
Ewha Med J 2021;44(2):37-40.   Published online April 30, 2021
DOI: https://doi.org/10.12771/emj.2021.44.2.37

Active surveillance (AS) of papillary thyroid microcarcinoma was first suggested by Dr. Akira Miyauchi at Kuma Hospital in 1993. Based on several subsequent evidences, AS was approved by the American Thyroid Association in 2015. AS is no longer an experimental treatment but has become an acceptable standard of care for patients with low-risk thyroid cancers. No molecular markers, such as BRAF mutations, have been identified to predict the prognosis of papillary thyroid cancer. However, future molecular studies may reveal the relationship between genetic mutations and thyroid cancer prognosis. AS involves closely monitoring thyroid cancer over time, instead of immediately treating it with surgery. Patients and medical doctors should consider these two options: observation or surgery.

  • 36 View
  • 0 Download
Case Reports
[English]
Primary Lymphoma of Cervix
Ji Eun Shim, Juhui Kim, Mi-Kyung Kim, Yun Hwan Kim, Seung Cheol Kim
Ewha Med J 2021;44(2):41-45.   Published online April 30, 2021
DOI: https://doi.org/10.12771/emj.2021.44.2.41

Lymphomas that originate from the female genital tract are very rare. Primary cervical lymphoma only accounts for less than 1% of all extra-nodal lymphomas. Clinical manifestations of primary cervical lymphoma can be nonspecific, vaginal bleeding being the most common symptom, and this makes timely diagnosis often difficult. Prognosis and optimal treatment have yet been established due to the rarity of the disease. In this article, a rare case of primary diffuse large B-cell lymphoma of cervix is reported with a review of the available literature.

Citations

Citations to this article as recorded by  
  • High-grade B-cell lymphoma with MYC and BCL2 rearrangements presenting as a cervical mass
    Chiao Lin, Leslie Kuma, Linda Shen
    Pathology.2024; 56(4): 588.     CrossRef
  • 46 View
  • 0 Download
  • 1 Web of Science
  • 1 Crossref
[English]
Unusual Case of Vesicoureteral Reflux and Chronic Kidney Disease in a 10-Year-old Boy with Asymptomatic Bacteriuria
Young Doo Choi, Ji Hyen Lee, Jung Won Lee
Ewha Med J 2021;44(2):46-49.   Published online April 30, 2021
DOI: https://doi.org/10.12771/emj.2021.44.2.46

Primary vesicoureteral reflux is a common genetically determined condition that is associated with varying degrees of renal scarring and represents one of the main causes of chronic kidney disease in children. Usually vesicoureteral reflux is common in urinary tract infection patient under 5 years of age. However, we report a rare case of high-grade vesicoureteral reflux and chronic kidney disease in a 10-year-old boy who was referred to the pediatric department for incidentally detected asymptomatic bacteriuria. Our case demonstrated that high grade vesicoureteral reflux patient with reduced renal function, bladder and bowel dysfunction at presentation is more likely to progress to chronic kidney disease.

  • 77 View
  • 2 Download
  • 1 Web of Science
TOP